Only 24 hours left

You are receiving this message because you opted in to receive information about our upcoming campaigns from InvestorPlace. If you don’t want to receive messages about this campaign in the future you can unsubscribe here but you will no longer receive reminders and supporting content for this campaign.   Dear Reader, There’s only 24 hours left until the Blockbuster FDA Approval offer expires. I’ve uncovered a little-known biotech company with just $7 million in revenue that could soon take on a $100 billion drug market. But the clock is ticking… This is your final chance to learn how to get in during the early stages…before final FDA review has occurred, and the biggest gains typically follow. Until midnight tomorrow, you can still become a member of my elite high-growth technology research advisory… and receive an entire FREE bonus year. We’re also including $14,696 worth of high-growth investment research bonuses for all new members. This will give you even more opportunities to bank triple-digit gains in the months to come. To look over all the bonuses that are included, click here. But remember: There’s only 24 hours left until this special opportunity expires. So if you’re interested, click here to claim your free bonus year, including the more than $14,000 worth of bonuses. Sincerely, Matt McCall Editor, Early Stage Investor   MANAGE YOUR INVESTORPLACE ACCOUNT: We hope this timely investing advice is valuable to you. As you know the markets move fast and conditions change frequently. So please check the current issue for the most recent advice. To make sure you received the most recent updates, please tell us if your email has changed by visiting here: https://investorplace.com/ipi/e/ Click here to unsubscribe. InvestorPlace Media, LLC. 9201 Corporate Blvd, Suite 200 Rockville, MD 20850 If you have any questions call 1-800-219-8592. Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. ————————————————————————————————- Please note that we cannot be liable for any missed bulletins caused by overzealous spam filters. To ensure that you continue to receive this valuable part of your service please take a moment to add (MattMcCall@exct.Investorplace.com) to your address book. Click here for instructions: http://www.investorplace.com/whitelist.html?eml=MattMcCall@exct.Investorplace.com